The authors with to add Lars Hellman and Parvin Ahooghalandari to the byline. The updated byline is: Kutty Selva Nandakumar1,2, Åsa Jansson3, Bingze Xu3, Niclas Rydell3, Parvin Ahooghalandari4, Lars Hellman4, Anna M. Blom5, Rikard Holmdahl12 The updated affiliations are: 1 Medical Inflammation Research, Department of Experimental Medicine, Lund University, Lund, Sweden, 2 Medical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden, 3 Resistentia Pharmaceuticals AB, Uppsala, Sweden, 4 Department of Cell and Molecular Biology, Uppsala University, Uppsala, Sweden, 5 Section of Medical Protein Chemistry, Department of Laboratory Medicine, Lund University, Skåne University Hospital, Malmö, Sweden The updated citation is: Nandakumar KS, Jansson Å, Xu B, Rydell N, Ahooghalandari P, et al. (2010) A Recombinant Vaccine Effectively Induces C5a-Specific Neutralizing Antibodies and Prevents Arthritis. PLoS ONE 5(10): e13511. doi:10.1371/journal.pone.0013511
Citation: Nandakumar KS, Jansson Å, Xu B, Rydell N, Ahooghalandari P, Hellman L, et al. (2011) Correction: A Recombinant Vaccine Effectively Induces C5a-Specific Neutralizing Antibodies and Prevents Arthritis. PLoS ONE 6(1): 10.1371/annotation/90e60d13-28ac-4eed-8104-893bead21eb7. https://doi.org/10.1371/annotation/90e60d13-28ac-4eed-8104-893bead21eb7
Published: January 22, 2011
Copyright: © 2011 . This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Competing interests: No competing interests declared.